| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $22.9M | -27.1% |
| SG&A Expense | $7.9M | -2.4% |
| Operating Income | -$30.8M | +22.0% |
| Pre-tax Income | -$29.9M | +23.8% |
| Income Tax | $20K | +15.1% |
| Net Income | -$29.9M | +23.8% |
| EPS (Basic) | -$0.90 | +45.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.5M | -42.3% |
| Current Assets | $14.7M | -38.0% |
| Total Assets | $15.5M | -34.6% |
| Current Liabilities | $14.6M | -15.0% |
| Total Liabilities | $14.7M | -18.3% |
| Stockholders' Equity | $813K | -85.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$33.5M | -18.4% |
| Financing Cash Flow | $23.7M | -28.7% |